Medication Regimen Reviews | Clinical Expertise | Park Shore Pharmacon
The medication regimen review is the most clinically consequential service a long-term care pharmacy provides beyond dispensing. It is the structured, pharmacist led process by which every resident’s complete drug regimen is examined for safety, appropriateness, and regulatory compliance on a recurring basis. When it is performed rigorously and followed through to prescriber action, it prevents adverse drug events, identifies unnecessary polypharmacy, supports CMS and AHCA survey readiness, and protects the residents in your facility from the medication related harms that accumulate quietly in complex, chronically ill populations.
When it is performed as a formality, it protects no one.
Park Shore Pharmacon’s medication regimen review program is built around the former standard. Our licensed pharmacists, including consultant pharmacists holding active Florida licensure under Section 465.0125 of the Florida Statutes, conduct monthly drug regimen reviews for every resident of every LTC facility we serve across all 67 Florida counties. This page describes what that process involves, what federal and Florida law requires, why it matters clinically and from a survey standpoint, and how Park Shore Pharmacon fulfills that responsibility.
The Federal Requirement: 42 CFR 483.45(c) and OBRA-87
Federal requirements for medication regimen review in Medicare and Medicaid participating nursing facilities stem from OBRA-87 and appear in 42 CFR 483.45(c). Park Shore Pharmacon supports facilities in meeting applicable pharmacy requirements, including monthly pharmacist review of each resident’s medication regimen and medical chart. Pharmacists must report identified irregularities to appropriate facility professionals and prescribers for review and documented follow up.
Clear procedures strengthen this process. Park Shore Pharmacon helps facilities organize workflows for pharmacist findings, prescriber communication, response documentation, and urgent medication related concerns. Federal requirements also direct nursing facilities to maintain policies that establish timeframes and procedures for drug regimen reviews, including appropriate steps when an irregularity may require immediate attention.
Strong LTC facility support connects these regulatory responsibilities with everyday medication workflows. Park Shore Pharmacon helps facility teams maintain organized pharmacy processes, documentation practices, and communication pathways that support review requirements. Licensed prescribers retain authority over treatment decisions, while facility leadership remains responsible for meeting applicable regulatory obligations.
What Constitutes an Unnecessary Drug Under Federal Regulations
The conceptual heart of the monthly medication regimen review is the identification of unnecessary drugs. Federal regulations at 42 CFR 483.45(d) define an unnecessary drug specifically. An unnecessary drug is any drug when used in excessive dose, including duplicate drug therapy; for excessive duration; without adequate monitoring; without adequate indication for its use; in the presence of adverse consequences which indicate the dose should be reduced or discontinued; or any combinations of these reasons.
Each element of this definition corresponds to a distinct clinical review task that our pharmacists perform for every drug on every resident’s regimen during the monthly medication regimen review:
Excessive Dose Review
Our pharmacists evaluate every medication dose against published dosing standards, resident specific factors including age, renal function, hepatic function, and body weight, and the clinical indication for which the drug was prescribed. For elderly residents, standard adult doses are frequently inappropriate, and our pharmacists apply geriatric dosing guidance as a routine component of every review.
Duplicate Therapy Identification
Therapeutic duplication, two or more drugs from the same pharmacological class prescribed simultaneously without clear clinical justification, is one of the most common and most correctable unnecessary drug findings in LTC populations. Our pharmacists screen every resident’s full medication list systematically for duplication across drug classes.
Duration Review
Many medications are prescribed appropriately for an acute condition but continued indefinitely after the clinical indication has resolved. Proton pump inhibitors, antibiotics, sleep aids, and antipsychotics initiated during an acute episode are among the most common examples. Our pharmacists review the indication, original start date, and documented rationale for every medication and flag those that appear to have exceeded an appropriate duration without clinical review.
Monitoring Adequacy Review
Certain medications require regular laboratory monitoring to ensure therapeutic appropriateness and safety. Warfarin requires INR monitoring. Lithium requires serum level monitoring. Antipsychotics in elderly patients require metabolic panel monitoring. Digoxin requires renal function and drug level monitoring. Our pharmacists identify medications requiring monitoring, assess whether that monitoring is current, and flag gaps to the prescriber and director of nursing.
Indication Review
Every medication on a resident’s regimen should have a documented clinical indication in the medical record. Our pharmacists review the documented indication for each drug and identify medications for which no clear indication is apparent. This review directly supports your facility’s compliance with CMS survey guidance under F-tag 757.
Adverse Consequence Screening
Our pharmacists screen every resident’s active medication list against their current clinical status for signs that a medication’s adverse effects may be causing or worsening another clinical problem, a pattern called a prescribing cascade. A common example is a resident prescribed a calcium channel blocker who then receives a laxative for medication induced constipation. Identifying and breaking prescribing cascades reduces polypharmacy and improves clinical outcomes.
The Irregularity Report: Documentation and Prescriber Communication
Clear documentation connects every medication regimen review finding with appropriate clinical follow up. Park Shore Pharmacon documents identified medication irregularities and communicates relevant findings to the attending physician and designated facility leadership according to applicable requirements. Our structured reports identify the resident, medication concern, relevant clinical information, and pharmacist recommendation so authorized clinicians can evaluate each finding.
Consistent follow up also strengthens accountability. Park Shore Pharmacon tracks outstanding reports and supports communication when a prescriber response remains pending under facility procedures. When clinicians determine that no medication change is appropriate, the facility maintains the required response documentation and clinical rationale. Urgent concerns follow established escalation procedures so appropriate professionals receive timely notification.
Organized records remain essential during regulatory review. Park Shore Pharmacon integrates irregularity reports, prescriber responses, and related documentation into our broader medical records support. This process helps facilities maintain accessible medication review histories while licensed prescribers retain authority over treatment decisions and facility leadership remains responsible for regulatory compliance.
Psychotropic Medication Review: F-Tags 757, 758, and Gradual Dose Reduction
Psychotropic medications, a category that includes antipsychotics, anxiolytics, sedative hypnotics, antidepressants, and other drugs affecting mental processes and behavior, receive heightened regulatory scrutiny during CMS and AHCA surveys. F-tag 757 addresses unnecessary non psychotropic medications, and F-tag 758 addresses psychotropic drugs specifically, requiring that residents who use psychotropic drugs receive gradual dose reductions (GDRs) and behavioral interventions unless clinically contraindicated. PRN orders for psychotropic medications are limited to 14 days, and PRN antipsychotic orders cannot be renewed without the attending physician first evaluating the resident.
Park Shore Pharmacon’s medication regimen review process includes a dedicated psychotropic medication review component for every resident receiving drugs in this category. Our pharmacists evaluate:
- Clinical indication documentation. Every psychotropic medication must have a specific, documented diagnosis or condition in the medical record that justifies its use. Our pharmacists identify psychotropic medications without adequate documented indication and report this finding to the prescriber and director of nursing for resolution.
- Gradual dose reduction status. For residents receiving antipsychotics and other psychotropic agents, our pharmacists assess whether a GDR has been attempted or formally documented as clinically contraindicated. Where GDR is indicated but not documented, we report this as an irregularity and work with the prescriber and clinical team to support the GDR process.
- PRN order compliance. Our pharmacists verify that PRN psychotropic orders comply with the 14 day limit, that antipsychotic PRN orders have not been renewed without physician evaluation, and that the condition being treated by the PRN order is documented in the clinical record.
- Non-pharmacological intervention documentation. CMS guidance requires that non-pharmacological interventions be attempted and documented before or alongside psychotropic medication use. Our pharmacists flag residents receiving psychotropic medications where the medical record does not reflect documented non-pharmacological intervention attempts.
- Monitoring parameters. Atypical antipsychotics in elderly patients require metabolic monitoring including weight, blood glucose, and lipid panels. Our pharmacists identify monitoring gaps and communicate them to the prescribing physician.
The Beers Criteria and High-Risk Medication Review in Elderly Residents
The American Geriatrics Society’s Beers Criteria for Potentially Inappropriate Medication Use in Older Adults provides evidence based guidance on medications that carry elevated risk in elderly patients, those for whom safer alternatives exist, and medications that require dose adjustment based on renal function in aging patients.
Park Shore Pharmacon’s pharmacists apply the current Beers Criteria as a systematic component of every medication regimen review for elderly residents. When a medication on a resident’s regimen appears on the Beers Criteria, our pharmacists evaluate whether the clinical indication justifies the continued use of that medication given its risk profile, whether a therapeutically equivalent and safer alternative is available, and whether the prescribing physician has documented awareness of and rationale for the Beers Criteria risk.
High alert medications that receive particular attention during our geriatric medication reviews include anticholinergic agents, which accumulate cognitive and fall risk in elderly populations; benzodiazepines, which are associated with falls, fractures, and cognitive impairment; first generation antihistamines; muscle relaxants; and non steroidal anti inflammatory drugs in patients with cardiovascular or renal risk factors.
Drug Regimen Review Across Florida LTC Facility Types
Different Florida care settings require medication regimen reviews that reflect their governing regulations and resident populations. Park Shore Pharmacon supports skilled nursing facilities with pharmacist led reviews, irregularity reporting, psychotropic medication considerations, and documentation workflows. Our broader consultant pharmacist services connect these reviews with clinical communication and facility focused pharmacy coordination.
Specialized residential environments require different approaches. Park Shore Pharmacon supports ICF/IID facilities with reviews aligned with applicable federal requirements, including communication of identified concerns to appropriate professionals. Our intermediate care facility pharmacy expertise also reflects the medication complexity of residents with intellectual and developmental disabilities. APD Waiver homes can receive medication focused pharmacy support for complex resident profiles.
Behavioral and end-of-life settings create additional considerations. Park Shore Pharmacon integrates behavioral health facility pharmacy expertise when medication profiles include complex psychotropic regimens. Our I/DD pharmacy workflows address residential developmental disability programs, while hospice pharmacy services support medication reviews within comfort focused care plans. Licensed clinicians retain responsibility for all treatment decisions.
Integration With Cycle-Fill, Technology, and the Care Team
Clinical findings become more useful when the medication regimen review connects directly with everyday pharmacy operations. Park Shore Pharmacon integrates pharmacist reviews with dispensing, documentation, and prescriber communication. When an authorized prescriber changes or discontinues medication following pharmacist review, our team updates the medication profile and coordinates the approved order through established pharmacy workflows.
Operational systems help carry authorized changes forward. Park Shore Pharmacon connects approved regimen updates with our cycle-fill services, helping facilities maintain organized maintenance medication schedules. Our technology integration capabilities also support prescription visibility and electronic documentation, allowing pharmacy and facility teams to work from current medication information and communicate relevant updates efficiently.
Nursing coordination completes the workflow. Park Shore Pharmacon connects medication related pharmacist findings with our consultant nursing services when those findings affect administration practices, documentation, or staff education. This coordinated model links clinical review with practical facility workflows while licensed prescribers retain treatment authority and facility leadership maintains responsibility for resident care and regulatory compliance.
FAQs: Medication Regimen Reviews in Florida LTC
- What is a medication regimen review, and why do nursing facilities require it?
A medication regimen review evaluates each resident’s medication profile for potential safety, appropriateness, and medication related concerns. Federal regulations establish review requirements for Medicare and Medicaid participating nursing facilities.
- What happens when a pharmacist identifies an irregularity during a medication regimen review?
Park Shore Pharmacon documents identified irregularities and communicates relevant findings to the attending physician and facility leadership. Appropriate clinicians review recommendations and document responses according to applicable regulatory requirements.
- How does psychotropic medication review differ from a general medication regimen review?
Psychotropic review examines additional considerations involving indication, duration, monitoring, PRN use, and applicable gradual dose reduction requirements. Park Shore Pharmacon evaluates these medications within current regulatory and clinical frameworks.
- How do medication regimen reviews support AHCA survey readiness?
Park Shore Pharmacon helps facilities identify medication related documentation and workflow concerns through structured reviews. Clear irregularity reports, clinician responses, and organized records can support pharmacy related regulatory readiness.
- Do medication regimen reviews apply to ICF/IID facilities and assisted living facilities?
Requirements differ by facility type. Nursing facilities, ICF/IID programs, and Florida assisted living facilities operate under different regulatory frameworks. Park Shore Pharmacon aligns pharmacy reviews with applicable requirements.
- How can facilities start Park Shore Pharmacon’s medication regimen review program?
Contact Park Shore Pharmacon at (954) 874-4646 or customerservice@parkshoredrug.com. Our team can review your facility’s medication workflows, documentation practices, and applicable pharmacy support needs.
Contact Park Shore Pharmacon’s Clinical Team
Park Shore Pharmacon’s licensed pharmacists conduct monthly medication regimen reviews for LTC facilities across all 67 Florida counties as an integrated component of our full service pharmacy program. If your facility is seeking a pharmacy partner whose drug regimen review process is thorough, documentable, and built to support both clinical quality and regulatory compliance, we welcome the conversation.
Contact us today to learn more about our medication regimen review program.
Park Shore Pharmacon
600 Ansin Boulevard
Hallandale Beach, FL 33009
Phone: 954.874.4646
Fax: 954.455.1378
Toll-Free Fax: 1-855-464-7779
General Inquiries: customerservice@parkshoredrug.com
Billing Department Inquiries: billing@parkshoredrug.com
Serving Florida’s long term care facilities with licensed pharmacist clinical oversight since 1958. Proud Member: Florida Assisted Living Association
Disclaimer: Information on this page is provided for educational and informational purposes regarding pharmacy regulatory and clinical standards and does not constitute legal, regulatory, or compliance advice specific to your facility. Consult a licensed pharmacist, attorney, or compliance professional regarding your facility’s specific drug regimen review obligations under applicable federal and Florida law.